血浆可溶性尿激酶型纤溶酶原激活物受体在急诊严重创伤患者病情评估中的应用研究

赵胤杰, 李杨, 沈亚静, 等. 血浆可溶性尿激酶型纤溶酶原激活物受体在急诊严重创伤患者病情评估中的应用研究[J]. 临床急诊杂志, 2021, 22(2): 81-86. doi: 10.13201/j.issn.1009-5918.2021.02.001
引用本文: 赵胤杰, 李杨, 沈亚静, 等. 血浆可溶性尿激酶型纤溶酶原激活物受体在急诊严重创伤患者病情评估中的应用研究[J]. 临床急诊杂志, 2021, 22(2): 81-86. doi: 10.13201/j.issn.1009-5918.2021.02.001
ZHAO Yinjie, LI Yang, SHEN Yajing, et al. Study on the application of plasma soluble urokinase type plasminogen activator receptor in the evaluation of emergency patients with severe trauma[J]. J Clin Emerg, 2021, 22(2): 81-86. doi: 10.13201/j.issn.1009-5918.2021.02.001
Citation: ZHAO Yinjie, LI Yang, SHEN Yajing, et al. Study on the application of plasma soluble urokinase type plasminogen activator receptor in the evaluation of emergency patients with severe trauma[J]. J Clin Emerg, 2021, 22(2): 81-86. doi: 10.13201/j.issn.1009-5918.2021.02.001

血浆可溶性尿激酶型纤溶酶原激活物受体在急诊严重创伤患者病情评估中的应用研究

  • 基金项目:

    重庆市技术创新与应用发展专项面上项目(No:cstc2019jscx-msxmX0222)

    陆军军医大学科技创新能力提升专项项目(No:2019XLC3001)

详细信息
    通讯作者: 向强,E-mail:xqiang163@163.com
  • 中图分类号: R641

Study on the application of plasma soluble urokinase type plasminogen activator receptor in the evaluation of emergency patients with severe trauma

More Information
  • 目的:探讨血浆可溶性尿激酶型纤溶酶原激活物受体(suPAR)和损伤严重度评分(ISS)、新损伤严重度评分(NISS)、改良早期预警评分(MEWS)对急诊严重创伤患者病情危重程度的评估价值。方法:纳入2019年12月—2020年10月期间我院急救部抢救室接诊并收住院的严重创伤患者,入院后检测血浆suPAR并完善上述评分,根据入院24 h内的急性生理学和慢性健康状况评分(APACHE)Ⅱ及序贯器官衰竭评分(SOFA)将患者分为危重组和一般组,比较两组患者的一般情况、ISS、NISS、suPAR和MEWS,采用多因素Logistic回归分析患者病情危重的独立预测因子,绘制受试者工作特征(ROC)曲线明确各指标的评估价值。结果:共纳入101例严重创伤患者,其中危重组34例(33.7%),一般组67例(66.3%),危重组患者的血浆suPAR水平、ISS、NISS和MEWS均显著高于一般组[(6.9±2.7)ng/mL vs.(5.0±2.0)ng/mL,P=0.000;29(26,34)分vs. 25(20,29)分,P=0.004;34(34,41)分vs. 33(27,34)分,P=0.001;4(3,5)分vs. 2(1,3)分,P=0.000],一般情况的组间差异无统计学意义(P>0.05);多因素Logistic回归分析显示入院时高MEWS、高血浆suPAR水平和高NISS是严重创伤患者病情危重的独立预测因子(OR=2.286,95%CI:1.501~3.482,P=0.000;OR=1.361,95%CI:1.062~1.744,P=0.015;OR=1.102,95%CI:1.014~1.198,P=0.022),ROC曲线下面积(AUC)分别为0.829(95%CI:0.741~0.896,P<0.001)、0.721(95%CI:0.623~0.806,P<0.001)、0.700(95%CI:0.601~0.788,P<0.001),取截断值>3分、>5.02 ng/mL、>33分时对应的敏感度和特异度分别为70.59%和83.58%、76.47%和61.19%、82.35%和53.73%;suPAR联合MEWS时AUC为0.857(95%CI:0.774~0.919,P<0.001),敏感度为73.53%,特异度为86.57%;suPAR联合NISS时AUC为0.819(95%CI:0.730~0.888,P<0.001),敏感度为91.18%,特异度为65.67%。结论:单独应用MEWS、血浆suPAR和NISS均能进一步评估严重创伤患者的病情危重程度,suPAR联合MEWS后评估效能最佳,更适用于急诊。
  • 加载中
  • [1]

    急诊预检分诊专家共识组.急诊预检分诊专家共识[J].中华急诊医学杂志,2018,27(6):599-604.

    [2]

    Ni W,Han Y,Zhao J,et al.Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults:a systematic review and meta-analysis[J].Sci Rep,2016,6:39481.

    [3]

    Hamie L,Daoud G,Nemer G,et al.SuPAR,an emerging biomarker in kidney and inflammatory diseases[J].Postgrad Med J,2018,94(1115):517-524.

    [4]

    Kumar P,Kakar A,Gogia A,et al.Evaluation of soluble urokinase-type plasminogen activator receptor(suPAR)quick test for triage in the emergency department[J].J Family Med Prim Care,2019,8(12):3871-3875.

    [5]

    Velissaris D,Dimopoulos G,Parissis J,et al.Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department:A Position Paper by the Hellenic Sepsis Study Group[J].Infect Dis Ther,2020,9(3):407-416.

    [6]

    Tranco S,Petrisor C,Hagǎu N,et al.Can APACHE Ⅱ,SOFA,ISS,and RTS Severity Scores be used to Predict Septic Complications in Multiple Trauma Patients?[J].J Crit Care Med(Targu Mures),2016,2(3):124-130.

    [7]

    黄文娟,覃松,孙宇,等.严重创伤患者MODS预警评分的建立及临床意义:一项多中心研究[J].中华危重病急救医学,2018,30(1):41-46.

    [8]

    Hongrattana G,Reungjui P,Tumsatan P,et al.Incidence and risk factors of pulmonary atelectasis in mechanically ventilated trauma patients in ICU:a prospective study[J].Int J Evid Based Healthc,2019,17(1):44-52.

    [9]

    张聪,邓海,李镇文,等.多发伤后急性胃肠功能损伤的影响因素研究[J].中华急诊医学杂志,2020,29(5):661-664.

    [10]

    中华医学会急诊医学分会,中国医师协会急诊医师分会,中国县级医院急诊联盟,等.中国县级医院急诊科建设规范专家共识[J].临床急诊杂志,2019,20(5):335-342.

    [11]

    Gussen H,Hohlstein P,Bartneck M,et al.Neutrophils are a main source of circulating suPAR predicting outcome in critical illness[J].J Intensive Care,2019,7:26.

    [12]

    Relja B,Land W G.Damage-associated molecular patterns in trauma[J].Eur J Trauma Emerg Surg,2020,46(4):751-775.

    [13]

    Darlington DN,Gonzales MD,Craig T,et al.Trauma-Induced Coagulopathy Is Associated with a Complex Inflammatory Response in the Rat[J].Shock,2015,44 Suppl 1:129-137.

    [14]

    Vourc'h M,Roquilly A,Asehnoune K.Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient[J].Front Immunol,2018,9:1330.

    [15]

    Park Y J,Liu G,Tsuruta Y,et al.Participation of the urokinase receptor in neutrophil efferocytosis[J].Blood,2009,114(4):860-870.

    [16]

    Yu L,Wu X,Wang H,et al.Diagnostic and prognostic significance of suPAR in traumatic brain injury[J].Neurol India,2014,62(5):498-502.

    [17]

    Backes Y,van der Sluijs KF,Tuip de Boer AM,et al.Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation:an observational cohort study[J].Crit Care,2011,15(6):R270.

    [18]

    Chen D,Wu X,Yang J,et al.Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity,inflammation and mortality[J].Exp Ther Med,2019,18(4):2984-2992.

    [19]

    Wu X,Hu K,Yu L,et al.Correlation of plasma suPAR expression with disease risk and severity as well as prognosis of sepsis-induced acute respiratory distress syndrome[J].Int J Clin Exp Pathol,2017,10(12):11378-11383.

    [20]

    Salottolo K,Carrick M,Johnson J,et al.A retrospective cohort study of the utility of the modified early warning score for interfacility transfer of patients with traumatic injury[J].BMJ Open,2017,7(5):e016143.

    [21]

    Rasmussen L,Ladelund S,Haupt TH,et al.Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor(suPAR)Improves Risk Prediction in Acute Medical Patients:A Registry-Based Cohort Study[J].Crit Care Med,2018,46(12):1961-1968.

  • 加载中
计量
  • 文章访问数:  183
  • PDF下载数:  167
  • 施引文献:  0
出版历程
收稿日期:  2020-12-17

目录